Anti‐vascular endothelial growth factor for neovascular glaucoma

This review (4 RCTs; n=263) found inconclusive evidence regarding long‐term effectiveness of anti‐VEGF medications, such as intravitreal ranibizumab or bevacizumab or aflibercept, as an adjunct to conventional treatment in lowering intraocular pressure in neovascular glaucoma.

Cochrane Database of Systematic Reviews